Skip to main content

University Of Texas/Texas Am Investment Management Co's Form 4 filing

Rein Therapeutics, Inc. (RNTX) · filed May 1, 2024

Accession no.
0001019231-24-000022
Filed
May 1, 2024
Trade date
Apr 29-May 1, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 24 non-derivative transactions. Open-market sales total $139.1K. It was filed 2 days after the trade.

This filing was later replaced by the amendment 0001019231-24-000023 (May 14, 2024). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
University Of Texas/Texas Am Investment Management CoCIK 000101923110% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 29, 2024Common StockSSaleDisposed−6,680$4.92−$32,865.61,803,777Direct
Apr 29, 2024Common StockSSaleDisposed−274$4.93−$1,350.821,803,503Direct
Apr 29, 2024Common StockSSaleDisposed−100$4.94−$4941,803,403Direct
Apr 29, 2024Common StockSSaleDisposed−3,231$5.00−$16,1551,800,172Direct
Apr 29, 2024Common StockSSaleDisposed−13$5.01−$65.131,800,159Direct
Apr 29, 2024Common StockSSaleDisposed−448$5.03−$2,253.441,799,711Direct
Apr 30, 2024Common StockSSaleDisposed−45$4.95−$222.751,799,666Direct
Apr 30, 2024Common StockSSaleDisposed−45$5.00−$2251,799,621Direct
May 1, 2024Common StockSSaleDisposed−3,100$4.10−$12,7101,796,521Direct
May 1, 2024Common StockSSaleDisposed−100$4.11−$4111,796,421Direct
May 1, 2024Common StockSSaleDisposed−1,750$4.12−$7,2101,794,671Direct
May 1, 2024Common StockSSaleDisposed−380$4.13−$1,569.41,794,291Direct
May 1, 2024Common StockSSaleDisposed−1,600$4.15−$6,6401,792,691Direct
May 1, 2024Common StockSSaleDisposed−670$4.15−$2,780.51,792,021Direct
May 1, 2024Common StockSSaleDisposed−400$4.18−$1,6721,791,621Direct
May 1, 2024Common StockSSaleDisposed−7,923$4.25−$33,672.751,783,698Direct
May 1, 2024Common StockSSaleDisposed−310$4.26−$1,320.61,783,388Direct
May 1, 2024Common StockSSaleDisposed−317$4.27−$1,353.591,783,071Direct
May 1, 2024Common StockSSaleDisposed−100$4.27−$4271,782,971Direct
May 1, 2024Common StockSSaleDisposed−200$4.28−$8561,782,771Direct
May 1, 2024Common StockSSaleDisposed−337$4.28−$1,442.361,782,434Direct
May 1, 2024Common StockSSaleDisposed−200$4.29−$8581,782,234Direct
May 1, 2024Common StockSSaleDisposed−2,903$4.29−$12,453.871,779,331Direct
May 1, 2024Common StockSSaleDisposed−25$4.32−$1081,779,306Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)